← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Nexbio, Inc.
San Diego, CA
$33,727,350
Total funding
7
Grants
Funding over time
peak $10.3M · FY2005–10$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$33,727,350 · 7
By mechanism
N01$19,999,028 · 1
R44$6,000,000 · 1
U01$4,672,698 · 1
R43$3,055,624 · 4
Investigators at Nexbio, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of DAS181 (Fludase^) as a Broad Spectrum Therapeutic Agent$9,999,863
N01 · FY2009 · AI
Development of DAS181 (Fludase^) as a Broad Spectrum Therapeutic Agent$9,999,165
N01 · FY2010 · AI
Development of Fludase for Prevention of Influenza$2,000,000
R44 · FY2005 · AI
Development of Fludase for Prevention of Influenza$2,000,000
R44 · FY2006 · AI
Development of Fludase for Prevention of Influenza$2,000,000
R44 · FY2007 · AI
Development of Fludase as an Anti-Influenza Agent$1,871,371
U01 · FY2006 · AI
Development of Fludase as an Anti-Influenza Agent$1,785,659
U01 · FY2008 · AI
Development of Fludase as an Anti-Influenza Agent$1,015,668
U01 · FY2007 · AI
Broad-Spectrum Therapeutics for Influenza$515,854
R43 · FY2003 · AI
A Novel Therapeutics for Pandemic &Epidemic Flu$500,000
R43 · FY2005 · AI
Novel Therapeutics for Pandemic and Epidemic Flu$500,000
R43 · FY2004 · AI
Identifying Broad-Spectrum Influenza Virus Inhibitors$449,902
R43 · FY2004 · AI
Broad-Spectrum Therapeutics for Influenza$402,411
R43 · FY2004 · AI
Identifying Broad-Spectrum Influenza Virus Inhibitors$387,459
R43 · FY2005 · AI
Proof-of-Principle Studies of DAS181 for Parainfluenza Virus Infection$299,998
R43 · FY2010 · AI